Hemp Business Journal predicts total U.S. CBD market growth to $2.1 billion by 2020, $450M from hemp-based sources.

Mr. Kent Deuters, CEO of MJ Biopharma, said: "Our goal has always been to monitor every step of the production process, from genetics, down to mining, to ensure only high-quality extracts are used in the design of our strip, the time of release of the capsule and other products currently In the development of medical and health hemp space. "
With the help of Vinergy, the European company has the ability to rapidly expand into hemp, hemp and cannabinoids (CANNABIDIOL) sectors throughout Europe. "The CBD revolutionized the global chronic anesthesia market and we determined that we can use our advantages to take the leading positions in the market in many countries," stressed the head of MJ Biopharma
The European leader company in the development of plant and plant genetics and has been providing clients with various commercial agricultural services for more than 25 years, with audited annual sales of the company exceeding Canadian $ 14,000,000 and adjusted EBITDA of more than $ 2,000,000. In 2016, they sent more than 35,000,000 plant products to the world market.

information sources:
https://www.hempbizjournal.com/category/exclusives/
http://j-p-g.net/